Fibroblast growth factor 7 pseudogene 6 (FGF7P6)

Fibroblast growth factor 7 pseudogene 6 (FGF7P6), also known as KGFLP1, is a processed pseudogene of the fibroblast growth factor (FGF) family, mapped to chromosome 9q13, with no coding potential for protein production[1][4][7][8]. It is catalogued in genomic databases (e.g., Ensembl: ENSG00000227449, Entrez: 387628), but it is not a functional gene, does not encode an active protein, and there is no evidence it acts as a regulatory or disease-associated non-coding RNA. As a processed pseudogene, FGF7P6 originated from reverse transcription and genomic integration of a parental transcript (in this case, likely FGF7), but without the capacity to produce a functional protein or act as a canonical drug target[5]. Current data indicate no therapeutic, pathogenic, or biomarker roles for FGF7P6 in human health or disease. Key points: - FGF7P6 is classified as a pseudogene, not a protein-coding gene, enzyme, receptor, or transporter[1][4][7]. - It is not referenced as a target for any drugs, and there is no known mechanism of action or safety consideration relevant to therapeutics targeting it. - Its biological function, if any, is unclear; most pseudogenes are non-functional, though rare regulatory roles are reported in some cases, not supported here for FGF7P6[5].

Other names

KGFLP1

Not applicable